Treatment of acute promyelocytic leukemia: A single institution experience. Tratamiento de la leucemia promielocítica aguda. Experiencia de una sola institución. A collection of disease information resources and questions answered by our Genetic and Rare Diseases Information Specialists for Acute promyelocytic. A leucemia promielocítica aguda (LPA) é um subtipo distinto de leucemia mieloide aguda (LMA), caracterizado pela presença de um acúmulo de promielócitos.
|Published (Last):||9 April 2014|
|PDF File Size:||12.89 Mb|
|ePub File Size:||1.39 Mb|
|Price:||Free* [*Free Regsitration Required]|
Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: Autologous and allogeneic stem-cell transplantation as salvage treatment of acute group.
Brit J Haematol ; Suppl. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Tricks of the trade for the appropriate management of newly diagnosed acute prpmielocitica leukemia. Early mortality represents almost all deaths and severe bleeding was the most important event leading to death.
Tratamiento de la leucemia promielocítica aguda: Experiencia de una sola institución
Postoperative tests showed acute promyelocytic leukemia with transposition 15;17 Treatment with ATRA and Idarubicin chemotherapy was initiated with the patients’s response being satisfactory.
Toxicity and survival in de novo patients.
Translocation 15;17 and trisomy 21 in the microgranular variant of acute promyelocytic leukemia. APL onset usually occurs in middle-aged adults where it manifests by fever, fatigue, dizziness, mild cough with expectoration, exercise-induced dyspnea, weight loss or loss of appetite.
Recognizing high-risk patients is crucial more aggressive support measures are promielocktica aiming to preventing an unfavorable outcome. Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
Trombose arterial em leucemia promielocítica aguda
Proteolysis of von Willenbrand factor is decreased in acute promielocytic leukemia by treatment with all-trans-retinoic acid. Implications for the clinical management of the disease. High frequency of acute promyelocytic leukemia among latinos with acute myeloid leukemia Letter.
Surveillance for any hemorrhagic signs is necessary, due to the high risk of disseminated intravascular coagulation.
¿Qué sucede si la leucemia mieloide aguda (AML) no responde o regresa después del tratamiento?
Mediterr J Hematol Infect Dis. Nonparametric estimations from incomplete observations. Am Soc Hematol Educ Program. Fibrinogenopenia and fibrinolysis in acute myelogenous leukemia. Fourteen patients were followed for more than 30 days and therefore, prospectively accrued in this study; they were observed for periods ranging from 67 to promielocutica, days median 1, Clinical bleeding leucemiaa and laboratory coagulation profiles in acute promyelocytic leukemia.
Management of acute promyelocytic leukemia: In addition, we elected to deliver ATRA fully on an outpatient basis, thus diminishing hospitalization costs. Role of maintenance chemotherapy in acute promyelocytic leukemia.
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Characterization of acute promielocytic leukemia cases lacking the classic t 15; The clinical course of APL has been modified in recent years, from rapidly fatal acute leukemia to one of the curable subtypes of AML.
A maior causa de morte foi a hemorragia grave, especialmente no sistema nervoso central SNC. Disease definition Acute promyelocytic leukemia APL is an aggressive form of acute myeloid leukemia AML; see this termcharacterized by arrest of leukocyte differentiation at the promyelocyte stage, due to a leucemi chromosomal translocation t 15;17 in myeloid cells.
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. Chromatin modulation by oncogenic transcription factors: The transcriptional role of PML and the nuclear body.
Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia Promieloctiica is feasible: Treatment of newly diagnosed acute promyelocytic leukemia APL: